Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02561988
Title (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Blueprint Medicines Corporation
Indications

hematologic cancer

mast cell neoplasm

Therapies

Avapritinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute Stanford California 94305 United States Details
University of Colorado Cancer Center Denver Colorado 80045 United States Details
Emory University Atlanta Georgia 30322 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
Mount Sinai Hospital New York New York 10029 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Beatson West of Scotland Cancer Centre Glasgow G12 0XL United Kingdom Details
Guy's Hospital London SE1 9RT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field